Benchmark Maintains Buy on Clene, Lowers Price Target to $5
Portfolio Pulse from richadhand@benzinga.com
Benchmark analyst Bruce Jackson maintains a Buy rating on Clene (NASDAQ:CLNN) but has lowered the price target from $7 to $5.
June 30, 2023 | 12:47 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Benchmark analyst Bruce Jackson maintains a Buy rating on Clene but has lowered the price target from $7 to $5.
The news is directly related to Clene and is likely to impact its stock price. While the maintained Buy rating is positive, the lowered price target could be seen as a negative signal, potentially leading to mixed reactions in the market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100